Charles River Laboratories
258 hedge funds and large institutions have $2.9B invested in Charles River Laboratories in 2014 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 90 increasing their positions, 103 reducing their positions, and 17 closing their positions.
118% more first-time investments, than exits
New positions opened: 37 | Existing positions closed: 17
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
23% more call options, than puts
Call options by funds: $6.55M | Put options by funds: $5.32M
16% more capital invested
Capital invested by funds: $2.49B → $2.9B (+$407M)
8% more funds holding
Funds holding: 239 → 258 (+19)
3.24% more ownership
Funds ownership: 97.62% → 100.86% (+3.2%)
13% less repeat investments, than reductions
Existing positions increased: 90 | Existing positions reduced: 103
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$72.1M |
| 2 |
Millennium Management
New York
|
+$39M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$35.2M |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$32.3M |
| 5 |
BlackRock
New York
|
+$27.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
-$96.5M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$52M |
| 3 |
AI
Ariel Investments
Chicago,
Illinois
|
-$36.1M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$28.6M |
| 5 |
FC
Fairpointe Capital
Chicago,
Illinois
|
-$26.9M |
CRL Hedge Fund Activity: Q1 2014 in Review
258 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Charles River Laboratories (CRL) for Q1 2014, worth a combined $2.9B — up 16% from $2.49B a quarter earlier.
Buyers outnumbered sellers: 37 funds opened new CRL positions and 17 closed out — a net gain of 20 holders — while 90 added to existing stakes and 103 trimmed.
The largest buyer was BlackRock Advisors, adding an estimated $72.1M. The largest seller was Perkins Investment Management, cutting an estimated $96.5M.
- 258 institutional investors held Charles River Laboratories (CRL) as of Q1 2014, up from 239 in Q4 2013.
- Funds reported $2.9B of Charles River Laboratories stock for Q1 2014, up 16% quarter-over-quarter.
- 37 funds opened new Charles River Laboratories positions in Q1 2014 and 17 closed out, a net change of +20 holders.
- The largest Charles River Laboratories buyer in Q1 2014 was BlackRock Advisors, an estimated $72.1M added.
- The largest Charles River Laboratories seller in Q1 2014 was Perkins Investment Management, an estimated $96.5M sold.
Based on aggregated 13F filings for Q1 2014.